Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis

Clinical trial NCT04823130 · COMPLETED

Trial details

NCT number: NCT04823130
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dermatitis Atopic

Start date: 2021-04-22
Primary completion: 2022-06-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.